Prostate artery embolization for benign prostatic hyperplasia: a retrospective single-center study of clinical outcome.

IF 1.4 4区医学 Q3 UROLOGY & NEPHROLOGY

Scandinavian Journal of Urology Pub Date : 2025-07-10 DOI:10.2340/sju.v60.44137

Jon Bjarnason, Johann Pall Ingimarsson, Hjalti Thorisson, Kristbjorn Reynisson, Jon Orn Fridriksson, Baldvin Thorkell Kristjansson, Fernando Bazan

{"title":"Prostate artery embolization for benign prostatic hyperplasia: a retrospective single-center study of clinical outcome.","authors":"Jon Bjarnason, Johann Pall Ingimarsson, Hjalti Thorisson, Kristbjorn Reynisson, Jon Orn Fridriksson, Baldvin Thorkell Kristjansson, Fernando Bazan","doi":"10.2340/sju.v60.44137","DOIUrl":null,"url":null,"abstract":"Objective: To evaluate clinical outcome and complications of prostate artery embolization (PAE) in Iceland, using the International Prostate Symptom Score (IPSS), quality of life (QoL) and catheter freedom to measure clinical success.Materials and methods: Retrospective single-center study, including patients who underwent PAE from August 2019 to February 2024 due to benign prostatic hyperplasia (BPH). Patients completed a questionnaire on lower urinary tract symptoms (LUTS), QoL, catheter status and use of medication. All additional data were retrieved from the medical records. Results: A total of 34 patients were included, with a mean age of 75 during PAE and a technical success rate of 91%. Patients had significant clinical improvement, with a mean reduction in IPSS score from 20.0 to 9.0 (p < 0.001) and QoL score from 5.5 to 1.8 (p < 0.001). PAE also resulted in a 69% reduction (p < 0.001) in urinary catheter dependency. Post-PAE complications were uncommon (3/34) and all resolved without long-term effects.Conclusion: PAE is an effective and safe treatment option for LUTS and/or urinary retention in men with BPH, offering catheter freedom and significant improvement in urological symptoms and quality of life.","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"60 ","pages":"130-134"},"PeriodicalIF":1.4000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2340/sju.v60.44137","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To evaluate clinical outcome and complications of prostate artery embolization (PAE) in Iceland, using the International Prostate Symptom Score (IPSS), quality of life (QoL) and catheter freedom to measure clinical success.

Materials and methods: Retrospective single-center study, including patients who underwent PAE from August 2019 to February 2024 due to benign prostatic hyperplasia (BPH). Patients completed a questionnaire on lower urinary tract symptoms (LUTS), QoL, catheter status and use of medication. All additional data were retrieved from the medical records. Results: A total of 34 patients were included, with a mean age of 75 during PAE and a technical success rate of 91%. Patients had significant clinical improvement, with a mean reduction in IPSS score from 20.0 to 9.0 (p < 0.001) and QoL score from 5.5 to 1.8 (p < 0.001). PAE also resulted in a 69% reduction (p < 0.001) in urinary catheter dependency. Post-PAE complications were uncommon (3/34) and all resolved without long-term effects.

Conclusion: PAE is an effective and safe treatment option for LUTS and/or urinary retention in men with BPH, offering catheter freedom and significant improvement in urological symptoms and quality of life.

查看原文本刊更多论文

前列腺动脉栓塞治疗良性前列腺增生：临床结果的回顾性单中心研究。

目的：采用国际前列腺症状评分（IPSS）、生活质量（QoL）和导管自由度（freedom）来衡量冰岛前列腺动脉栓塞（PAE）的临床疗效和并发症。材料与方法：回顾性单中心研究，纳入2019年8月至2024年2月因良性前列腺增生（BPH）行PAE的患者。患者完成关于下尿路症状（LUTS）、生活质量、导尿管状态和药物使用的问卷调查。所有其他数据都是从医疗记录中检索的。结果：共纳入34例患者，平均年龄75岁，技术成功率91%。患者有显著的临床改善，IPSS评分从20.0降至9.0 (p < 0.001)，生活质量评分从5.5降至1.8 （p < 0.001）。PAE还导致尿管依赖减少69% （p < 0.001）。pae后并发症罕见（3/34），均无长期影响。结论：PAE是治疗前列腺增生男性LUTS和/或尿潴留的一种有效且安全的治疗选择，可以自由使用导管，显著改善泌尿系统症状和生活质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Scandinavian Journal of Urology UROLOGY & NEPHROLOGY-

CiteScore

2.90

自引率

6.70%

发文量

期刊介绍： Scandinavian Journal of Urology is a journal for the clinical urologist and publishes papers within all fields in clinical urology. Experimental papers related to clinical questions are also invited.Important reports with great news value are published promptly.